General Information of Drug (ID: DM1FJW6)

Drug Name
BT8009
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Drug Type
Bicycle?toxin conjugate
Cross-matching ID
PubChem CID
167312193
TTD ID
DC57TE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Nectin cell adhesion molecule 4 (NECTIN4) TTPO9EG NECT4_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04561362) Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumors Malignancies. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Bicycle Therapeutics.